EUVIMEDEUVIMED entdecken
Crossref

CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation

Lin-Ying Xie

International Journal of Clinical and Experimental Medicine · 2025

DOI: 10.62347/hftc6895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2025. Verfasst von Lin-Ying Xie. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Xie, L. (2025). CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/hftc6895

Vancouver

Xie L. CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation. International Journal of Clinical and Experimental Medicine. 2025. doi:10.62347/hftc6895

BibTeX
@article{Xie2025,
  author = {Xie, Lin-Ying},
  title = {CD36 promotes chemotherapy resistance and stemness of cervical cancer cells through the Hippo and ERK5 pathway activation},
  journal = {International Journal of Clinical and Experimental Medicine},
  year = {2025},
  doi = {10.62347/hftc6895}
}
Kostenlos starten →